Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 3 Neuroblastoma 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Stomach Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Nerve Sheath Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Hodgkin Disease 1 Giant Cell Tumor of Bone 1 Desmoplastic Small Round Cell Tumor 1 Clear-cell metastatic renal cell carcinoma 1 Chordoma 1 Chondrosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Metastatic 1

Interventions

Doxorubicin 6 Specimen Handling 5 Radiotherapy 3 Radiation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Biopsy 3 pembrolizumab 2 liposomal doxorubicin 2 eribulin 2 Ifosfamide 2 toripalimab 1 talimogene laherparepvec 1 rucaparib 1 ribociclib 1 regorafenib 1 peposertib 1 pazopanib 1 olaratumab 1 olaparib 1 lenvatinib 1 futibatinib 1 durvalumab 1 dinutuximab 1 cemiplimab 1 cediranib 1 cabozantinib 1 avelumab 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Zoledronic Acid × 1 year × Clear all

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡